Ergoteles’s BELLUS Health Inc. BLU Stock Holding History

Ergoteles’s Portfolio BLU Stock Details BLU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-53,779	Closed	-$387K	–	1700
2023 Q1	$387K	Buy	+53,779	New	+$417K	0.02%	826

Other funds holding BLU

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

VAM

Vazirani Asset Management New York $43.4M AUM 84.05% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

GLAM

Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

SAM

Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

Canada Life Winnipeg, Manitoba, Canada $55.8B AUM 26.04% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return

Ergoteles's BLU Position: Q2 2023 in Review

Ergoteles sold out of BELLUS Health Inc. (BLU) in Q2 2023, closing a stake of 53,779 shares — an estimated $387K sold.

Ergoteles first reported a position in BLU in Q1 2023 and held it in 1 quarter. The position peaked at $387K in Q1 2023. 11 funds tracked by Wall St. Rank hold BLU as of Q2 2023.

Ergoteles reported no remaining BELLUS Health Inc. position as of Q2 2023 after selling out during the quarter.
Ergoteles sold 53,779 BELLUS Health Inc. shares in Q2 2023, an estimated $387K.
Ergoteles first reported a position in BELLUS Health Inc. in Q1 2023 and held it in 1 quarter.
Ergoteles's BELLUS Health Inc. position peaked at $387K in Q1 2023.
11 funds tracked by Wall St. Rank held BELLUS Health Inc. as of Q2 2023.

Based on Ergoteles's 13F filing for Q2 2023, filed 14 Aug 2023.